Status:
COMPLETED
Eliminating HCV in Rural South Carolina Utilizing NP Led Mobile Clinics and Virtual Care Coordination
Lead Sponsor:
Prisma Health-Upstate
Collaborating Sponsors:
Gilead Sciences
Conditions:
Hepatitis C
Substance Use Disorders
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Up to 150 individuals with current hepatitis C (HCV) will be recruited from mobile health clinics in rural South Carolina - sites will be selected based on HCV prevalence rates and lack of current HCV...
Eligibility Criteria
Inclusion
- Not previously treated with HCV direct-acting antiviral medications OR treatment-experienced and eligible for treatment with sofosbuvir/velpatasvir
- Age 18+
- Willing to be randomized to either emocha versus TAU arms
- Able to provide informed consent
Exclusion
- Pregnant or breastfeeding
Key Trial Info
Start Date :
September 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 16 2023
Estimated Enrollment :
146 Patients enrolled
Trial Details
Trial ID
NCT05369507
Start Date
September 1 2021
End Date
September 16 2023
Last Update
April 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prisma Health Upstate
Greenville, South Carolina, United States, 29605